» Articles » PMID: 35208518

Vitamin D Implications and Effect of Supplementation in Endocrine Disorders: Autoimmune Thyroid Disorders (Hashimoto's Disease and Grave's Disease), Diabetes Mellitus and Obesity

Overview
Publisher MDPI
Specialty General Medicine
Date 2022 Feb 25
PMID 35208518
Authors
Affiliations
Soon will be listed here.
Abstract

: Vitamin D deficiency is involved in numerous pathologies, including endocrine pathology. The purpose of this review consists of presenting the role of vitamin D in the pathophysiology of certain endocrine disorders, autoimmune thyroid disorders (Hashimoto's disease and Grave's disease), diabetes mellitus, and obesity, and whether its supplementation can influence the outcome of these diseases. : Review articles and original articles from the literature were consulted that corresponded with the thematic. : Vitamin D deficiency is frequently encountered in endocrine disorders and supplementation restores the normal values. In Hashimoto's disease, vitamin D deficiency appears to be correlated with a higher titer of anti-TPO antibodies and with thyroid volume, and supplementation was associated with reduction of antibodies in some studies. In other studies, supplementation appeared to reduce TSH levels. In Grave's disease, there was a significant correlation regarding vitamin D levels and thyroid volume respective to the degree of exophthalmos. In diabetes mellitus type 2 patients, supplementation led to some improvement of the HOMA-IR index and HbA1c, whereas obesity data from literature do not report significant beneficial findings. : Vitamin D deficiency is highly prevalent in endocrine disorders and its supplementation appears to have numerous beneficial effects.

Citing Articles

A retrospective analysis on maternal and neonatal outcomes in pSS/AITD pregnancies.

Peng M, Luo T, Weng X, Dong Y, Xie Y, Huang S Sci Rep. 2025; 15(1):3437.

PMID: 39870646 PMC: 11772809. DOI: 10.1038/s41598-024-83937-9.


Assessment of Vitamin Concentrations in Patients with Hashimoto's Thyroiditis and Their Relationships with Thyroid Function, Biochemical Status, and Anthropometric Parameters-A Preliminary Study.

Mikulska-Sauermann A, Resztak M, Karazniewicz-Lada M, Filipowicz D, Ruchala M, Glowka F Nutrients. 2024; 16(11).

PMID: 38892627 PMC: 11174579. DOI: 10.3390/nu16111694.


Differences in Plasma 25-Hydroxyvitamin D Levels at Diagnosis of Celiac Disease and Type 1 Diabetes.

Marino M, Galeazzi T, Gesuita R, Ricci S, Catassi C, Cherubini V Nutrients. 2024; 16(5).

PMID: 38474871 PMC: 10934773. DOI: 10.3390/nu16050743.


Elucidating the role of phytocompounds from var. italic (Broccoli) on hyperthyroidism: an in-silico approach.

Daniel D, Shanmugasundaram S, Chandra Mohan K, Siva Bharathi V, Abraham J, Anbazhagan P In Silico Pharmacol. 2024; 12(1):6.

PMID: 38187876 PMC: 10766920. DOI: 10.1007/s40203-023-00180-2.


Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency.

Pludowski P Nutrients. 2023; 15(17).

PMID: 37686757 PMC: 10489803. DOI: 10.3390/nu15173725.


References
1.
Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J . Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006; 36(2):361-70. DOI: 10.1002/eji.200425995. View

2.
Kundu R, Theodoraki A, Haas C, Zhang Y, Chain B, Kriston-Vizi J . Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Immunology. 2016; 150(1):55-63. PMC: 5167305. DOI: 10.1111/imm.12669. View

3.
Wang X, Zynat J, Guo Y, Osiman R, Tuhuti A, Zhao H . Low Serum Vitamin D Is Associated with Anti-Thyroid-Globulin Antibody in Female Individuals. Int J Endocrinol. 2015; 2015:285290. PMC: 4670662. DOI: 10.1155/2015/285290. View

4.
Kust D, Matesa N . The impact of familial predisposition on the development of Hashimoto's thyroiditis. Acta Clin Belg. 2018; 75(2):104-108. DOI: 10.1080/17843286.2018.1555115. View

5.
Ghitea T, Aleya L, Tit D, Behl T, Stoicescu M, Sava C . Influence of diet and sport on the risk of sleep apnea in patients with metabolic syndrome associated with hypothyroidism - a 4-year survey. Environ Sci Pollut Res Int. 2021; 29(16):23158-23168. DOI: 10.1007/s11356-021-17589-x. View